Analyst Ratings for Moderna (MRNA) [Buys]
MRNA Rating Summary
MRNA Price Target Summary
- Highest: $231.00 (Goldman Sachs)
- Lowest: $68.00 (Leerink Partners)
- Average: $136.53
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
=
Avg. $ Target:
$136.53 (+69.4%)
* Over Last 12-Mos
Rating Score: 3.7 / 10
Percentile Rank: 35%
Rating Score: 3.7 / 10
Percentile Rank: 35%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 6/26/2023 | UBS » Updated 11/6/2023 |
Eliana Merle | Upgrade | Buy (Neutral) |
143.00 (178.00) |
120.48 (80.60) |
-33.1% | Details |
| 12/19/2022 | Jefferies » Updated 11/3/2023 |
Michael Yee | Upgrade | Buy (Hold) |
100.00 (175.00) |
207.25 (80.60) |
-61.11% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
